IL5 and hypereosinophilic syndrome: However, IL-5 elevations have also been observed with higher doses of mepolizumab (750 mg) and with other “hypereosinophilic” diseases, such as hypereosinophilic syndrome and eosinophilic esophagitis [4,40].